在喘中开发药物的新目标
Ian M Adcock1, Gaetano Caramori, K Fan Chung
1Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
Lancet (London, England)
|September 23, 2008
概括
全球有3亿人患有喘,5-10%患有严重的,难以治疗的疾病. 未来的疗法将针对特定的炎症途径进行个性化喘管理.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种慢性呼吸道炎症疾病,影响全球3亿人,预计将增加.
- 虽然大多数患者对吸入性皮质类固醇和β-激动剂有反应,但5-10%的患者患有严重的耐火性喘.
- 了解喘表型的进展揭示了不同的炎症特征,指导了针对性治疗,如抗胰岛素和奥马利祖马布.
研究的目的:
- 审查有关喘病理生理学和炎症机制的当前知识.
- 讨论针对特定途径和媒介的新兴治疗策略.
- 探索个性化医疗在严重喘治疗中的潜力.
主要方法:
- 关于喘病理生理学,表型和治疗进展的文献综述.
- 对当前和研究中的治疗药物的分析.
- 讨论喘研究和临床管理的未来方向.
主要成果:
- 识别与特定炎症类型相关的不同喘表型.
- 确定新的治疗点,包括p38 MAPK,抗氧化剂,IL-13和免疫调节细胞.
- 组合疗法在严重喘中克服皮质类固醇不敏感性的潜力.
结论:
- 对呼吸道炎症机制的进一步研究对于改善喘疗法至关重要.
- 针对性疗法和组合治疗的开发对治疗严重喘具有前景.
- 基于不同喘亚型的个性化治疗策略是未来的目标,尽管治愈仍然遥远.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

